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Honey bees (Apis mellifera) are facing multiple stressors affecting their lifespan, health
and productivity. Among them, Nosema ceranae is an intracellular microsporidian
parasite, which plays a major impact on honey bees colonies. However, both efficiency
and innocuity of current treatment against N. ceranae are being questioned, thus
raising the urgent need to develop alternative prophylactic and curative strategies.
Endogenous microbial communities (i.e., host microbiota) are known to play a major role
in disease prevention, and more recently both bacterial and yeast strains issued from
gut microbiota were observed to improve hosts resistance against intracellular parasites
both in mammals and insect models. The use of probiotics in honey bee nutrition
is therefore promising to treat or prevent diseases. Therefore, further investigations
are needed to properly select microorganisms with probiotic properties. In an in vivo
experimental infection by N. ceranae, the probiotic effect of two honeybee gut bacterial
strains (Parasaccharibacter apium (PC1 sp.) and Bacillus sp. (PC2 sp.)), and two broad
spectra probiotics (Bactocell® and Levucell SB®) has been measured. Both curative and
prophylactic administrations were tested: honey bees infected with N. ceranae and non-
infected. For the four probiotic candidates, significant increases of survival probabilities
(20–30%) were measured after two weeks of treatment with the administration of 103
CFU/mL in sugar syrup, both in curative and prophylactic treatments. The present study
shows that endogenous bacterial strains were at least as much efficient and safe than
broad spectra probiotics in increasing survival in the context of experimental infection
with N. ceranae. Therefore, taking advantage of beneficial host microbiota properties
is a promising avenue to develop efficient and sustainable curative strategies against
opportunistic diseases in honey bee colonies.
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INTRODUCTION
The European honey bee Apis mellifera is the most important
pollinator present in the agricultural (Alberoni et al., 2016)
environmental and economic sectors (Klein et al., 2017). Over
the last few decades, major mortalities in honey bee colonies
have been reported globally (Fairbrother et al., 2014; Vanegas,
2017). With the intensive exploitation of honey bees for the
pollination of agricultural crops, bee colonies mortality is more
accentuated in some area as Europe and US than in others
part of the world. Although the stock of honey colonies is
increasing, it fails to meet our actual needs (Aizen and Harder,
2009; Smith et al., 2014). Numerous studies agree that synergetic
interactions between multiple abiotics (Doublet et al., 2014;
Alburaki et al., 2015; Kakumanu et al., 2016; Poquet et al.,
2016; Li et al., 2017; López et al., 2017) and biotics stressors
(Goulson et al., 2015; Dussaubat et al., 2016) are involved
as major causes of bee colonies decline (see also reviews by
Fairbrother et al., 2014; Alberoni et al., 2016; Sánchez-Bayo
et al., 2016; Klein et al., 2017). Synergies between many of
these factors have a strong negative impact on immune defense
(Nazzi et al., 2012; Di Prisco et al., 2013), metabolism (Koch
and Schmid-Hempel, 2011; Dussaubat et al., 2013; Bordier
et al., 2017), and on bees cognitive mechanisms (Klein et al.,
2017).
Now, honey bee gastrointestinal microorganisms (i.e., gut
microbiota) are known to play a critical role in regulating
specific functions associated with metabolism and immune
response (Evans and Lopez, 2004; Alberoni et al., 2016;
Hyrsl et al., 2017). Microbial symbionts participate in various
processes such as digestion of food (Koch and Schmid-Hempel,
2011), detoxification of harmful molecules, supply of essential
nutrients, participation in the host’s defense system (Lemaitre
and Hoffmann, 2007; Hooper et al., 2012), and protection against
pathogens and parasites (Evans and Lopez, 2004; Flint et al., 2012;
Engel and Moran, 2013; Alberoni et al., 2016; Chaplinska et al.,
2016). Although our understanding of mechanisms underlying
interactions between the intestinal microbiota and parasites is
still partial, it is widely acknowledged that the composition of
the intestinal microbiota is a key factor in controlling infection
dynamics (Berrilli et al., 2012). To this respect, members of
the gut microbiota, including parasites, can be either beneficial,
neutral or harmful to their host (Engel and Moran, 2013).
Furthermore, according to the host physiological state, some
strains can shift from opportunistic to infectious when the
host is stressed (Boutin et al., 2013), and potentially favor
parasite infections. Nosema ceranae is an obligate intracellular
microsporidian parasite, which is the causative agent of one of
the most prevalent honey bee disease, called nosemosis (Higes
et al., 2008). Honey bee’s infection occurs by proliferation of
N. ceranae spores in the midgut after the incorporation of
infected food (Ptaszynska et al., 2014) and spore accumulation
is often associated with mortalities (Higes et al., 2007, 2008, 2009;
Martín-Hernández et al., 2007).
Nosemosis disease is involved in physiological and behavioral
perturbations in the honey bee colony (Leoncini et al., 2004;
Goblirsch et al., 2013) like the disruption of the pheromone
production, the ethyl oleate (EO). Ethyl oleate (EO) is involved
in the behavioral maturation, in the transition from hive work
to foraging activities (Leoncini et al., 2004; Dussaubat et al., 2010,
2013) and suppression of the cellular immune response (Antúnez
et al., 2009). Nosemosis is also correlated with a modification
of the natural feeding behavior of honey bees, making them
less cooperative to participate in trophallaxis process (Naug and
Gibbs, 2009). Nosema ceranae infection mainly impacts colony
robustness (Cox-Foster et al., 2007; Antúnez et al., 2009): infected
honey bees are more susceptible to other pathogens (Mayack and
Naug, 2009).
Furthermore, spore accumulation is suspected to cause
gut microbiota dysbiosis and to impair the defense system
of the host (Alberoni et al., 2016). Dussaubat et al. (2012)
showed that N. ceranae triggers inhibition of gene expression
involved in the regeneration of the gut epithelial tissue (e.g.,
Wnt signaling pathway), which in turn could affect the
ecological niche of beneficial host microbes. Gut epithelial tissue
damages are symptoms of intestinal diseases, including diarrhea.
Overall, intracellular intestinal protozoan parasites impact can
be extremely damaging, especially in individuals who have
weakened immune system (Vitetta et al., 2016). Given that
modern agroenvironments exert a strong negative impact on
immune defense, (Alaux et al., 2010; Di Prisco et al., 2013), it
is not surprising that nosemosis prevalence is rapidly increasing
(Higes et al., 2008).
Current treatment against nosemosis homologated in many
countries (for example USA and Canada) is the antibiotics
Fumagillin-B R© and Fumidil-B R© (Van Den Heever et al., 2015).
Unfortunately, Nosema spp. strains are showing various levels
of antibiotic-resistance (Huang et al., 2013) and several studies
have measured reduced Fumagillin-B R© efficacy on both N. apis
and N. ceranae infections (Pajuelo et al., 2008; Williams et al.,
2011). For this reason, Fumagillin-B R© was recently banned
in the European Union (Gisder and Genersch, 2015) like in
France in 2002 (Fernandez and Coineau, 2007). Furthermore,
antibiotics showed to disrupt host microbiota equilibrium by
killing endogenous bacteria (Aguilera et al., 2013; Li et al., 2017).
Moreover, antibiotics were observed to increase the susceptibility
to Nosema infection, thus inducing a negative impact on the
honey bee lifespan (Li et al., 2017).
Therefore, there is a need to develop effective and sustainable
alternative strategies to maintain or restore intestinal flora
homeostasis. Alternatively, beneficial microorganisms (i.e.,
probiotics) were successfully used as therapeutic tools in animal
production (Hamdi et al., 2011; Alberoni et al., 2016). Oral
administration of probiotics has showed a protective effect on
the intestinal microbiota of the host (Gismondo et al., 1999).
In murine models, both bacterial and yeast probiotic strains
have also proven their effectiveness against intracellular parasites
and showed positive improvement of the health of host (Alak
et al., 1997, 1999; Benyacoub et al., 2005; Humen et al., 2005;
Shukla et al., 2008; Dinleyici et al., 2011). Concerning honey
bees, endogenous gut bacteria belonging to Lactobacilliaceae,
Bifidobacteriaceae, and Acetobacteraceae families have been
found to play an antagonistic role against N. ceranae, either in
caged bee trial or in field conditions, by reducing the spore load
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(Sabaté et al., 2012; Audisio et al., 2015; Baffoni et al., 2016;
Corby-Harris et al., 2016).
Our research goal focused in comparing the probiotic
potential of two endogenous strains [Parasaccharibacter apium
(PC1 sp.), Bacillus sp. (PC2 sp.)] and two commercial probiotics
strains (Bactocell R© and Levucell SB R©, Lallemand Inc.) as an
alternative treatment against N. ceranae infections in honey
bees. These four probiotic candidates were targeted either for
their proven or putative probiotic properties. The endogenous
strains [P. apium (PC1 sp.) and Bacillus sp. (PC2 sp.)] are
respectively closely and distantly related to strains that have
been successfully used to inhibit honeybee disease (Sabaté
et al., 2009; Yoshiyama and Kimura, 2009; Corby-Harris et al.,
2016) and to enhance colony performance (Sabaté et al.,
2012). Parasaccharibacter apium (PC1 sp.) belongs to the
Acetobacteraceae family, which is particularly abundant in honey
crop, hypopharyngeal glands, royal jelly, and larval gut through
nurse worker bees feeding behavior (Corby-Harris et al., 2016).
Overall, commensal Acetobacteraceae affect tissue development
in insects such as in Anopheles mosquitoes (Chouaia et al.,
2012; Mitraka et al., 2013) and control maturation of gut
immunity, such as in Drosophila melanogaster (Ryu et al.,
2008). Then, Bacillus sp. (PC2 sp.) belongs to the phylum
Firmicutes and more specifically to the Bacillus genus. Bacillus
species are dominant in the honeybee stomach (Wang et al.,
2015). This genus can survive at high temperatures and pH
and is usually harmless, with the exception of B. anthracis
and B. cereus (Sabaté et al., 2012). Administration of Bacillus
strains helped the development of bee colonies by enhancing
the brood and also honey yield (Sabaté et al., 2012). Concerning
the commercial strains, Bactocell R© (Pediococcus acidilactici), is a
Lactobacillaceae that is used for a wide range of host species: pigs,
chickens, shrimps, and salmonids (EFSA, 2012). Bactocell R© was
demonstrated to improve the laying performance of hens (Denev
et al., 2013), the survival rate, and the growth of the shrimp
L. Stylirostris (Castex, 2009). Lactobacillacea strains are used as
probiotics formulations in animals (Nikoskelainen et al., 2003;
Bovera et al., 2012; Piccolo et al., 2015; Billiet et al., 2017) and
in honey bees (Evans and Lopez, 2004). Interestingly, a decrease
of Lactobacillaceae sp. was correlated with unhealthy honey bees
(Cox-Foster et al., 2007; Olofsson and Vásquez, 2008), thus
highlighting the important role of this bacterial family in honey
bee health. Levucell R©SB (Saccharomyces cerevisiae boulardii) is
used for monogastrics (swine and chicken) to improve growth
performance, gut histology (Le Bon et al., 2010), decrease carriage
of foodborne pathogens (Mountzouris et al., 2015) and improve
immunity response (Collier et al., 2011). Moreover, other studies
showed positive impact of commercial probiotic on bee host
(Kazimierczak-Baryczko and Szymas, 2006; Ptaszynska et al.,
2016). Consequently, we decided to test the impact on honey bee
health of two commercial strains, Bactocell R© and Levucell R©SB
that showed beneficial effects on other animals.
The main objective of the present study was to compare the
survival of young caged bees fed with two endogenous honey
bee gut bacteria (PC2 and PC1) and two commercial probiotics
(Bactocell R©, Levucell SB R©, two trademarks of Lallemand Inc.),
experimentally infected by N. ceranae. This work is one of
the very first studies comparing commercial probiotics, which
usually have a broad host range, with honey bee endogenous
strains, to assess whether beneficial members of the commensal
gut microbial community perform better both in prophylactic
and curative conditions. The motivation of this study is that
probiotic curating strategies based on broad range commercial
probiotic strains such as acid bacteria commercial strains
such as L. rhamnosus and Lactobacillus sp. were not able
to prevent nosemosis, and disrupted the honeybee immune
system (Andrearczyk et al., 2014; Ptaszynska et al., 2016).
Moreover, Andrearczyk et al. (2014) observed an increase of
Nosema spp. infections in young honeybees fed with commercial
Lactobacillus sp. and Saccharomyces cerevisiae probiotic strains.
Finally, some cases of commercial probiotic induced microbiota-
host perturbations were documented (Doron and Snydman,
2015; Durchschein et al., 2016). Taken together, this suggests that
some broad range probiotics are not necessary suitable for the
honey bees nutrition (Andrearczyk et al., 2014).
The present study shows that both endogenous bacterial
strains were at least as much efficient and safe as broad spectra
probiotics in significantly increasing survival in the context of
experimental infection with N. ceranae.
MATERIALS AND METHODS
Isolation and Culture of Honeybee Gut
Bacteria
Sixty healthy adult worker honey bees were collected from
five different colonies at the Centre de Recherche en Sciences
Animales de Deschambault (CRSAD, Deschambault, Qc,
Canada) and transported alive to the Institute for Integrative and
Systems Biology (IBIS) in Quebec city, Canada. Upon arrival,
whole bee guts were removed from the abdomen. Bee guts
were then macerated, vortexed and placed into a sterile 10mL
Snap-cap tube (Sarstedt Inc. No. 62.554.002 PP∗) filled with 5mL
of PBS 1X (Phosphate buffered saline). Gut bacterial community
was prepared for culture by using several dilutions (10−1 to
10−4) from the starting volume of PBS 1X. Then, 100 µL of these
different dilutions were transferred onto petri dishes of Tryptic
Soy Broth agar (TSB) (Difco Inc.) and on De Man-Rogosa-
Sharpe agar (MRS) (Difco Inc.), both incubated at 37◦C for 48 h
under aerobic conditions. After 48 h, individual colonies were
picked and transferred to new agar plates to obtain pure strains.
Each strain was transferred in a 2mL cryotube for long-term
storage by adding sterile glycerol to a final concentration of
15%; frozen samples were stored at −80◦C for further molecular
characterization and culture.
DNA Extraction and PCR Amplification of
Endogenous Probiotic Strains 16S rRNA
Gene
For DNA extraction, isolated strains were sampled from
their specific media. Then, DNA was extracted using
the Dneasy Blood and Tissues kit (Qiagen Inc., 2016) as
indicated in the manufacturer’s protocol with the following
modifications: cultured strains were suspended in 200 µL
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of PBS 1X followed by a thermal shock at 95◦C for 5min.
Next protocol steps were completed as indicated in the
manufacturer’s protocol (Pretreatment for Gram-Positive
Bacteria In DNeasy R© Blood & Tissue Handbook. 2006). For
the PCR amplification, 16S rRNA gene was targeted using
the universal bacterial primers (Sigma-Aldrich,Genosys)
F-Tot (5′-GCAGGCCTAACACATGCAAGTC) and 1389R
(5
′
-AGGCCCGGGAACGTATTCAC). The PCR was conducted
in a total volume of 50 µL: H2O 18 µL; TaKaRa Taq 25 µL, F-tot
(10µM) 25 µL; 1389R (10µM) 25 µL; DNA 2 µL. After initial
denaturation at 95◦C for 2min, amplification was performed
using 30 cycles of 1min at 95◦C, 1min at 55◦C and 1min 30
at 72◦C followed by a final extension at 72◦C for 5min. Then,
amplification products were run on 2.0% agarose gels and sent
to the “Plate-forme d’Analyses Génomiques” of Laval University
for a Sanger DNA sequencing. Taxonomic identification of 16S
rRNA gene sequences was completed using the BLAST sequence
analysis tool of NCBI databases.
Survival of Endogenous and Commercial
Probiotic Strains in Sugar Syrup
Endogenous bacterial strains used in this research were obtained
from the glycerol stock (storage at −80◦C) and streaked on
Tryptic Soy Broth agar (TSB) or De Man-Rogosa-Sharpe agar
(MRS) plates. Plates were incubated at 37◦C for 48 h under
aerobic conditions. After 48 h, 5–6 colony-forming unit (CFU)
were inoculated in 10mL of sugar syrup (1:1, w:v). In parallel,
commercial probiotics were also inoculated in 10mL of sugar
syrup (1:1, w:v). Subsequently, 1mL cultures of each solution
(syrup sugar+CFU) were plated onMRS and TSA agarmedium,
depending on the bacterial strain, at T = 0, 48 h, 72 h, and 1, 2,
3 weeks in triplicate. All plates were incubated at 37◦C for 48 h
under aerobic conditions. Survival of two endogenous and two
commercial probiotics in sugar syrup was measured by counting
CFU after 2 days of incubation on their respective culture media.
Honey Bee Cages, Experimental
Conditions, and Nosema spp. Infection
Experiments were conducted at the Centre de Recherche en
Sciences Animales de Deschambault (CRSAD, Deschambault,
46◦40′26.85′′N, 71◦54′54.39′′W), Québec, Canada. The effect of
endogenous and commercial probiotics against Nosema spp.
infection was investigated in vivo on adult honeybees, maintained
in cages under laboratory conditions. All bees used in this study
originated from four European honeybee colonies (A. mellifera
L.) headed by sister queens in September 2015. Accordingly
to the methodology described by Williams et al. (2013), five
combs of capped brood with dark eyes and gray skin pupae were
transferred in a “nursery colony” that consisted of a Langstroth
hive body with a frame of honey and pollen for food supply. To
obtain newly emerging bees, the nursery colony was placed in
an incubator (model 3040, Forma Scientific Inc., Ohio, U.S.A.)
adjusted at 35◦C and 55% relative humidity for 6 days. Young
bees of 4–6 days old were placed in a 4 frame hive body before
being randomly distributed to cages. Each cage consisted of a 14
oz. single-use plastic ventilated cup (Evans et al., 2009) and an
inverted sterile syringe (20mL, BD, Franklin Lakes, New Jersey,
U.S.A.) containing sucrose syrup. Bees rapidly learned to take
the syrup from the bottom opening of the syringe. Twenty bees
were randomly distributed in each cage and all cages were kept
in an environmentally controlled room (30◦C ± 1◦C and 50%
± 5% relative humidity) in total darkness for the duration of
the experiment (27 days). Cages were randomly distributed in
each experimental group (Table 1) and treatments begun on day
0. Each experimental group was composed of 20 cages. Five
cages per experimental group were sampled each time. There
are four treatment groups, one per probiotic strain: Bactocell R©,
Levucell SB R©, PC1, and PC2. For each treatment group there
are two conditions, curative vs. prophylactic administration, and
two controls: with and without Nosema, therefore totalitizing 10
experimental groups.
To induce Nosemosis, N. ceranae spores were obtained
directly before experiments from naturally infected honey
bee ventriculus as described by Fries et al. (2013). To
insure homogenous experimental infection of Nosema across
experimental group, Nosema spore concentration in sugar syrup
was checked three times before administration. To ensure that
all bees had low Nosema infection level, we used newly emerged
bees (4–6 days old) from healthy colonies, which were checked
by PCR for Nosema prevalence. One micro liter of a sucrose
syrup (1:1, w:v) containing 1 000 000 Nosema ssp. spores were
administrated orally to Nosema group cages on day 0, with the
inverted syringe. Following spore administration, endogenous
or commercial probiotics were fed according to protocol with
a dose of 103 CFU per mL. Commercial probiotics Bactocell R©
and Levucell R© were supplied by Lallemand Inc. (Lallemand,
2016, Montréal, Québec, Canada) while endogenous probiotic
candidates were isolated from healthy adult honeybee guts (as
described in previous section). Each probiotic strain was mixed
thoroughly in sucrose syrup (1:1, w:v). Sucrose solution was
replenished weekly with a freshly made solution in all cages.
Every 2 days, the number of dead bees was recorded in each cage
to evaluate mortality rate in each group. On day 0, 50 bees were
sampled to assess N. ceranae infection. Then, once a week until
day 27, five cages per group were randomly sampled, and bee
samples were stored at −80◦C for further genomic analyses and
evaluation of N. ceranae presence in honeybee gut.
Molecular Detection of Nosema
Total DNA for each sample (a pool of 5 bees per cage, 5
cages per experimental group) was extracted from intestinal
honeybee using a rapid salt-extraction as described in (Aljanabi
and Martinez, 1997) with some modifications. Intestinal tissues
were removed from the bees stored at −80◦C and placed into a
1.5mL microtube. We added 440 µL of sterile salt homogenizing
buffer (0.4M NaCl 10mM Tris–HCl pH 8.0 and 2mM EDTA
pH 8.0), 40 µL of 20% SDS and 8 µL of 20 mg/mL proteinase
K (400µg/mL final concentration) in the 1.5mL microtube and
vortexed for few seconds. Next, the samples were incubated
at 60◦C for at least 1 h and vortexed every 20min. Then, 300
µL of 6M NaCl was added to each sample followed by a
centrifugation for 20min at 13,300 rpm at 4◦C. The supernatant
was transferred in a new 1.5mL microtube. After this step, 600
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TABLE 1 | Experimental groups (20 bees in each cage for a total of 400 bees in each experimental group).
Group Sample size
(cages)
Nosema infection
(1M spores/cage)
Probiotic
(10E3 CFU/mL)
Sucrose
(50% w/v)
1. Control 20 – – Day 0–27
2. Nosema 20 Day 0 – Day 0–27
3. Bactocell 20 – Day 1–27 Bactocell Day 0–27
4. Nosema + Bactocell 20 Day 0 Day 1–27 Bactocell Day 0–27
5. PC1 P. apium 20 – Day 1–27 PC1 Day 0–27
6. Nosema + PC1 20 Day 0 Day 1–27 PC1 Day 0–27
7. PC2 Bacillus 20 – Day 1–27 PC2 Day 0–27
8. Nosema + Bacillus 20 Day 0 Day 1–27 PC2 Day 0–27
9. Levucell SB 20 – Day 1–27 Levucell Day 0–27
10. Nosema + Levucell SB 20 Day 0 Day 1–27 Levucell Day 0–27
Sample size (second column): each experimental group contained 20 cages of 20 bees for a total of 400 bees per experimental group; infection time with Nosema ceranae in infected
experimental groups (third column); administration time of probiotics in their respective experimental group (fourth column); administration period of the sugar syrup in all groups (fifth
column).
µL of cold isopropanol was added and incubated at −20◦C
for 30min. Centrifugation was repeated before collecting the
supernatant. This step was repeated twice, and the pellet was
dried overnight. The dried pellet was suspended in 100 µL of
sterile water and stored at 4◦C. Then, N. ceranae was detected
by PCR amplification. The Nosema gene marker was targeted
using the primers (Sigma-Aldrich, Genosys), L203 (5′-CAGTTA
TGGGAAGTAATATTATATTG) and R253 (5′-TTGATTTGC
CCTCCAATTAATCAC). The PCR was conducted in a total
volume of 50µL: Non- acetylated BSA (1mg/mL) (20µL; dNTPs
(2.5mM) (4 µL); Forward primer, L203 (3µM) 2.5 µL; Reverse
primer, R253 (3µM) 2.5 µL; MgCl2 (25mM) (2.5 µL); reaction
buffer (10X) (Feldan); Taq (Feldan (10 U/µL) 25 µL, H2O 12.2
µL and DNA 1 µL. After initial denaturation at 94◦C for 2min,
amplification was performed using 29 cycles of 45 s at 94◦C, 45s
at 56◦C and 45s at 72◦C followed by a final extension at 72◦C for
5min. Then, amplification products were run on 2.0% agarose
gels for the detection of the specific 250 pb DNA fragments,
together with a 100 pb DNA Ladder.
Molecular Detection of Endogenous
Probiotic Candidates
Parasaccharibacter apium sp. (PC1) Detection
Total RNA for each sample (a pool of 5 bees per cage, 5
cages per experimental group) was extracted from intestinal
honeybee using TRIzol R© Reagent protocol from Invitrogen
(Chomczynski, 1993) as described in Boutin et al. (2015).
Complementary DNA (cDNA) was synthesized using qScriptTM
cDNA SuperMix (Quanta Biosciences). A total RNA of 0.5
µg was mixed with 4 µL qScriptTM cDNA SuperMix and a
variable volume of nuclease free water to obtain 20 µL as
total volume, following the manufacturer’s instructions (Quanta
BioSciences, Inc. 2013). Then, standard PCR was conducted on
Sigma (Biometra R© T1 plus thermocycler, Montreal Biotech Inc.)
PCR was carried out in a total volume of 12.5 µL: TaKaRa 6.25
µL; Primer M3_325_Fw (5′-GAAGCCGGCATCGTGGCCTG)
(Sigma-Aldrich, Life Science) 1.25 µL; Primer M3_325_Rv (5′-
ATGTACACGGCATCTGTCCA) (Sigma-Aldrich, Life Science))
1.25 µL; cDNA template 1.875 µL and H2O 1.875 µL.
After initial denaturation at 94◦C for 1min, amplification was
performed using 41 cycles of 30 s at 94◦C, 30 s at 60◦C and 45 s at
72◦C followed by a final extension at 72◦C for 10min.
Bacillus sp. (PC2) Detection
Detection was realized on genomic DNA, using extraction
protocol as described in Aljanabi and Martinez (1997) followed
by two successive DNA purifications and a standard PCR
conducted on Sigma (Biometra R© T1 plus thermocycler,
Montreal Biotech Inc.) PCR was carried out in a total volume
of 12.5 µL: TaKaRa 6.25 µL; Primer B3_339_Fw (5′-AAA
AACTCGGTGGCGTAATG) (Sigma-Aldrich, Life Science) 1.25
µL; Primer B3_339_Rv (5′-TCAACACCTTTTAAGGGTGC)
(Sigma-Aldrich, Life Science)) 1.25 µL; DNA template 1.875 µL
and H2O 1.875 µL. After initial denaturation at 94◦C for 1min,
amplification was performed using 26 cycles of 30 s at 94◦C, 30 s
at 60◦C and 45 s at 72◦C followed by a final extension at 72◦C for
10min. Then, amplification products were run on 2.0% agarose
gels for both endogenous probiotic.
Quantification of Nosema ceranae Spore
Loads in Honeybee Gut
For each experimental group, five bees from one cage were
randomly sampled and pooled together to detect N. ceranae
occurrence using an adapted protocol derived from Fries et al.
(2013). In summary, we proceed as follow: All materials
were cleaned with 70% ethanol. The five dissected abdomens
were grinded into 5mL of distilled water within a mortar
using a pestle. Then, large debris were removed and mortar
contents were poured into a 10mL flacon tube and stored
overnight at 4◦C. Next, spore counting was performed using a
hemocytometer grid. The hemocytometer grids were sterilized
with 70% ethanol and a KimWipesTM, then the preparation
was homogenized manually by vortexing. Afterwards, a glass
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coverslip was put over the hemocytometer grid. Then, 20 µL of
each pooled sample were placed into the hemocytometer. The
hemocytometer was placed on an optical microscope equipped
with a 400x magnification lens for observation. All the analyses
were performed at day 14 (bees age = 18–20 days) of the
experience. For the spore loads count, pools of 5 bees per cage
were analyzed. Spore counting was performed in duplicate to
reduce variability (Figure 1). Estimation of the number of spores
per bee gut were calculated with the following formula: [(Raw
spore count from 5 blocks) ∗ 50.000)] = number of spores per
bee.
Statistical Analysis
Survival analysis of the in vivo experiment was performed with
the Kaplan-Meier Method using R language (R Development
Core Team, 2008). Kaplan-Meier analysis illustrates survival
probabilities of bees between groups during the 27 days
experiment by taking into account the censored data that
represent sampling of cages during the in vivo experiment.
Data mortality registered for each cage was formatted using
script from our group and survival individuals were analyzed
using “Survival” R package. Survival curves of multiple groups
were obtained with the Kaplan-Meier (Kaplan and Meier,
1958) formula (fitted Cox model). Kaplan-Meier estimate
generally assumes independence among the individual death
events. In order to determine over time and for specific
time if there is a statistically significant difference between
control (non-infected group) vs. experimental group (curative
and prophylactic groups) and within experimental groups we
performed a Cox’s proportional hazards regression using the
coxph function in R. The hazard function or death rate is the
instantaneous probability of death for individuals still alive.
The Cox regression model estimates the hazard ratio of dying
when comparing treatment vs. control (non-infected group).
The P-values from the Cox model summary indicate the
significance of differences between compared groups (Package
survival, R).
Nosema prevalence was assessed by quantifying the number
of N. ceranae spores per bee and per cup independently for each
experimental group at day 14. The significance of differences
between our collected data was evaluated by using a Variance test
(test ANOVA) in R (Tables 2, 3).
A single factor analysis of variance (ANOVA) was
performed to test whether significant differences in terms
of survival differential occurred between prophylactic
(i.e., probiotic vs. control) and curative (i.e., Nosema +
probiotic vs. Nosema control) use of the four probiotic strains
(Table 7).
FIGURE 1 | Estimation of the number of spore per bee in each experimental group: pictures were taken from an hematocytometer placed on an optical microscope
equipped with a 400x magnification lens for observation. Five bees per experimental group were grinded together. For spore counting, we used 5 blocks (four blocks
localized in the grid corner and the one in the 5 × 5 grid centrum). Each block represents 4 × 4 grids (16 squares). Pictures illustrated in this figure represent one of
the smaller 4 × 4 grids (16 squares) from the 5 × 5 grids that are used for spore counting.
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RESULTS
Survival of Endogenous and Commercial
Probiotics in Sugar Syrup
We showed that the amount of CFUs for both endogenous and
commercial probiotic candidates were stable after 3 weeks in
the sugar syrup (1:1) (sugar:water), thus confirming that the
syrup formulation was suitable for the administration of the four
probiotics candidates. After 3 weeks, a ten-fold decrease of CFU
counts was recorded for the four probiotic candidate strains.
To be conservative, the syrup formulation (1:1) (syrup sugar +
CFUs) used in this study was renewed weekly.
Nosema ceranae Spore Titers in the
Experimental Groups
Nosema ceranae was unambiguously identified with the
amplification of a taxonomic marker (See methods). At T0 (prior
to Nosema infection), diagnostic PCR was negative. N. ceranae
spores were recorded neither in control (non-infected group)
TABLE 2 | Spore counts statistics on infected groups with Nosema ceranae.
Nosema Bactocell P. apium Bacillus sp. Levucell
Min.: 32.75 Min.: 27.30 Min.: 32.55 Min.: 27.05 Min.: 25.20
1st Qu.: 32.86 1st Qu.: 28.25 1st Qu.: 35.89 1st Qu.: 35.52 1st Qu.:26.02
Median: 33.02 Median: 29.20 Median: 39.65 Median: 49.85 Median: 30.00
Mean: 33.04 Mean: 35.95 Mean: 44.47 Mean: 49.27 Mean: 36.73
3rd Qu.: 33.20 3rd Qu.: 45.34 3rd Qu.: 54.50 3rd Qu.: 54.96 3rd Qu.: 46.24
Max.: 33.35 Max.: 51.35 Max.: 59.80 Max.: 78.20 Max.: 56.85
NA s: 6 NA s: 4
TABLE 3 | ANOVA on spore counts in infected groups with Nosema ceranae.
Df Sum Sq Mean Sq F-value Pr(>F)
Ind 4 1390 347.4 1.956 0.123
Residuals 35 6218 177.7
(group 1) nor in probiotic controls (group 3, 5, and 9) at day
14. A minimal occurrence of spore was however observed in the
Bacillus, probiotic candidate (group 7). Then, strong occurrences
of N. ceranae spores were recorded in all of the infected groups
(2, 4, 6, 8, and 10; See Tables 2, 3; Figure 2).
Honey Bee Survival
During this 27 days experiment, cumulative mortalities were
recorded every 2 days and survival probabilities for each group
were estimated by comparison of the Kaplan-Meier curves
obtained and illustrated in Figure 3.
Effect of Nosema ceranae Infection on
Honeybee Survival
Significant differences of survival probabilities between all
groups were found from the second week of the experiment
(day 8 to day 14) to the last day (day 27). Table 4 shows
the Cox model comparisons of survival probabilities between
control group (non-infected group) and all others groups. On
day 25, all groups receiving probiotic candidates exhibited
significantly higher survival rates compared to the control group
(non-infected group; Table 4). Cox Proportional Hazard model
comparisons showed that honey bees infected with N. ceranae
had a significantly lower survival probability than bees from the
control group (non-infected group) on day 18 (13.5% less), 25
(10.6% less), and 27 (9,5% less), evidencing the negative effect of
N. ceranae infection on honey bee survival.
Prophylactic Administration of Commercial
Probiotics (Bactocell® and Levucell SB®)
Overall, honey bees receiving a prophylactic administration of
Bactocell R© and Levucell SB R© had a significantly higher survival
probability than the non-infected control group (Cox-model,
Figures 3A,B). From day 14 to day 27, survival probabilities of
bees receiving a prophylactic dose of the commercial probiotic
Bactocell R© were significantly higher than those of control group
bees receiving sucrose syrup. At day 18, bees have a significant
higher survival probability (Kaplan-Meier curves, + 30%) than
bees from the control group (54.2% ± 2.49 and 83.0% ±
FIGURE 2 | Spore counts per bee in the experimental groups infected with Nosema ceranae. Fifteen bees sampled at day 14 were analyzed (5 bees per experimental
group, one cage per experimental group).
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A B
C D
FIGURE 3 | Kaplan-Meier Survival curves distribution of bees in each experimental group during the 27 days cage bee experiment. The y-axis represents the
Kaplan-Meier estimates of the survival probabilities. The x-axis represents the experimental days. (A) Effect of Bactocell® administration (prophylactic: Bactocell®
group and curative: Nosema + Bactocell) on honeybee survival. (B) Effect of Levucell® administration (prophylactic: Levucell group and curative: Nosema + Levucell)
on honeybee survival. (C) Effect of PC1 sp. (Parasaccharibacter apium probiotic candidate) administration (prophylactic: PC1 sp. group and curative: Nosema + PC1
sp.) on honeybee survival (D) Effect of PC2 sp. (Bacillus probiotic candidate) administration (prophylactic: PC2 sp. group and curative: Nosema + PC2 sp.) on
honeybee survival.
TABLE 4 | Cox Proportional Hazard model (Cox-model) comparisons between survival of the control group (ctrl) and Nosema group and experimental groups with
curative administration of tested probiotics during the 27 days experiment.
Days 8 10 12 14 18 20 22 25 27
Ctrl vs:
Nosema – – – – 0.0201 – – – 0.0038
Nosema + Bactocell – – – <0.001 – 0.013 <0.001 <0.001 0.0009
Nosema + P. apium – – – <0.001 – – <0.001 <0.001 0.0001
Nosema + Bacillus sp. – – 0.0495 <0.001 0.0052 0.0004 <0.001 <0.001 <0.001
Nosema + Levucell SB – <0.001 – 0.0243 <0.001 <0.001 <0.001
Significant p-values < 0.05.
1.89, respectively for control and Bactocell R© group). Similarly,
honey bees fed with the commercial probiotic Levucell SB R©
also showed a significantly higher survival probability when
compared to the control group at day 8, 14, and from day 20
to 27 (Figure 3B, Table 5). On day 22, survival probability of
bees receiving a prophylactic dose of the commercial probiotic
Levucell SB R© was 75.4% ± 2.15 compared to 45.5% ± 2.49)
which is a significant increase of 29.9% of survival rate.
Prophylactic Administration of
Endogenous Probiotics
Overall, honey bees receiving a prophylactic administration of
endogenous probiotics PC1 and PC2 had a significantly higher
survival probabilities than bees of the non-infected control
group, from the third week of the experiment (Table 5) to the
last day (day 27). On day 22, honey bees receiving a prophylactic
dose of PC1 had a significant increase of survival (Cox model,
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TABLE 5 | Cox Proportional Hazard model (Cox-model) comparisons between survival of the control group (ctrl) and probiotic controls groups during the 27 days
experiment.
Days 8 10 12 14 18 20 22 25 27
Ctrl vs:
Bactocell 0.0004 0.0004 <0.001 <0.001 – – – <0.001 <0.001
P. apium – – – <0.001 – – <0.001 <0.001 <0.001
Bacillus sp. – – – 0.0005 – 0.0263 <0.001 <0.001 <0.001
Levucell SB 0.0136 0.0136 – <0.001 – 0.0056 <0.001 <0.001 <0.001
Significant p-values < 0.05.
TABLE 6 | Cox Proportional Hazard model (Cox-model) comparisons between survival of the artificial Nosema infection groups (Nosema ctrl) and experimental groups
with curative administration of tested probiotics during the 27 days experiment.
Days 8 12 14 15 18 20 22 25 27
Nosema ctrl vs:
Nosema + Bactocell – 0.0094 <0.001 0.0002 – 0.0077 <0.001 <0.001 <0.001
Nosema + P. apium – – <0.001 <0.001 0.0019 0.05 <0.001 <0.001 <0.001
Nosema + Bacillus sp. 0.0441 0.0151 <0.001 – – 0.0002 <0.001 <0.001 –
Nosema + Levucell SB – – – <0.001 0.0121 0.0107 <0.001 <0.001 –
Significant p-values < 0.05.
+ 30%), when compared to survival of the control group (75.5%
± 2.09 compared to 45.5% ± 2.49). Prophylactic administration
of the PC2 candidate also correlated with significantly higher
survival probabilities on day 14 and 20 to 27 when compared to
the control group. The highest survival difference was recorded
at day 20: 83.0% ± 1.88 of bee receiving a prophylactic dose of
the PC2 candidate survived, while 50.5% ± 2.5 of bees of the
non-infected control group survived.
Curative Administration of Commercial
Probiotics
Bees receiving a curative administration of Bactocell R© after
N. ceranae infection (test group 4) showed significant higher
survival rates than control group (non-infected group) and
Nosema infected control group bees from day 14 to the end of the
in vivo experiment (Tables 4, 6, Figure 3A). On day 22, Kaplan-
Meier curves indicate a survival rate of 34.2%± 2.37 for Nosema
control group and 60.5% ± 2.43 for the Nosema + Bactocell R©
test group (i.e., group receiving a curative dose of Bactocell R©),
representing a survival increase of 26.3%. Identically, Nosema +
Levucell SB R© test group showed significant higher survival rates
than in Nosema control group. On day 14, survival rates were
71.0%± 2.27 for theNosema control group and 87.0%± 1.68 for
the Nosema + Levucell SB R© test group, representing a survival
increase of 16%. On day 22, bees from the Nosema + Levucell
SB R© test group had 75.4% ± 2.15 survival rate compared to
34.2%± 2.37 for Nosema infected group, which is 41.2% higher.
Curative Administration of Endogenous
Probiotics
The survival probabilities of bees receiving a curative
administration of the endogenous probiotic candidate PC1
after an artificial infection of N. ceranae (Nosema + PC1 test
group, group 6) showed significant higher survival probabilities
compared to Nosema control group bees (group 2) from day 14
to day 27 (Table 6, Figure 3D). Survival rates were significantly
higher in the group 6 compared to group 2 from day 14 until the
end of the experiment (32.7% ± 2.35 and 53.5% ± 2.49). Finally,
infected bees receiving the endogenous probiotic candidate
PC2 (Nosema + PC2 test group, group 8) showed a significant
increase of survival from day 14 to day 27 (Table 6, Figure 3C),
compared to Nosema control group. At day 27, a significant
survival increase of 19.9% (52.6%± 2.57% vs. 32.7%± 2.35) was
observed for the Nosema+ PC2 test group.
Survival Differential Between Curative
Groups and Prophylactic Groups
Significant differences regarding survival differential between
prophylactic groups (i.e., probiotic vs. control) and curative
groups (i.e., Nosema + probiotic vs. Nosema control) were
detected from day 15 onwards. Survival differential between
curative and prophylactic groups was significant for Levucell
SB R© at T15, T18, T20, T22, T25. For PC2, survival differential
between curative and prophylactic groups was significant at
T15, T18, T25. Finally, for Bactocell R©, survival differential
between curative and prophylactic groups was only significant at
T25.
DISCUSSION
The results clearly showed that both prophylactic and curative
administration of all the four probiotics candidates, either with
broad host range and endogenous, significantly increased honey
bees survival rates from 20 to 40% when compared to the
non-infected control group. For a prophylactic administration,
highest survival rates were obtained for (in decreasing order):
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PC1, Bactocell R©, Levucell SB R©, and PC2. For the curative
administration, highest survival rates were obtained for (in
decreasing order): Levucell SB R©, PC1, PC2 and Bactocell R©.
However, there was no significant difference in terms of survival
improvement between commercial and endogenous probiotic
candidates.
Regarding the patterns of survival rates, a drastic decrease
was observed at day 14 in both control and Nosema control.
From day 14 to the end of the trial (day 27), the Nosema
control group survival was always lower than the control
without Nosema, thus confirming that Nosema infection exerted
a negative effect on survival. Furthermore, this drastic decrease
did not occurred in the groups fed with probiotics, either with
or without Nosema infection. This result strongly suggests that
probiotics were very efficient to improve bee survival both
in curative and prophylactic mode of action. Regarding the
cause itself of this drastic survival decrease at day 14 in both
control and Nosema control, we observed a similar pattern
of sudden survival decrease in a preliminary trial (data not
shown), although to a lower extent. We would hypothesize
that maintaining honey-bees in cages fed without protein
intake (i.e., pure 1:1 sugar syrup) triggered microbiota dysbiosis
and in turn gut inflammation. In the probiotic fed groups,
it is very likely that both anti-microbial effects and positive
immune response stimulations, which were demonstrated for
both Bactocell R© and Levucell SB R©, in alternative host organisms
(Qamar et al., 2001; Standen et al., 2013), mitigated gut
dysbiosis, thus increasing survival rate. Then, from day 15
onwards, we observed significant differences regarding survival
differential between curative groups (i.e., Nosema + probiotic
vs. Nosema control) and prophylactic groups (i.e., probiotic vs.
control; Table 7). Basically, survival differential between curative
and prophylactic groups varied from one experimental group
to another, and from one sampling time to another. This
result suggest that under curative use, at least three out of
the four tested probiotic strains had a non-additive effect on
survival relative to prophylactic use. Therefore, although it may
suggest these three probiotic strains exert a specific effect on
Nosema activity, further experiments are needed to univocally
assess whether there is a direct functional interaction with the
parasite.
Finally, despite of the significant increase of survival rate
in curative groups, no significant reduction of Nosema spores
was observed in any of the four probiotic groups. At first
sight, this result may be surprising as significant decreases of
TABLE 7 | ANOVA single factor analysis of variance was performed to test
whether significant differences in terms of survival occurred between prophylactic
and curative administration of probiotics (significant p-values < 0.05).
Days 14 15 18 20 22 25
Bactocell – – – – – 0.0086
P. apium – – – – –
Bacillus – 0.0110 0.0295 – – 0.0110
Levucell SB – 0.0012 0.0010 0.0076 0.0296 0.0431
N. ceranae spore loads were recorded in previous studies: Baffoni
et al. (2016) combined several strains of microorganisms isolated
from the honeybee gut and found that both Bifidobacteriaceae
and Lactobacilliaceae strains were correlated with a significant
decrease of N. ceranae spore loads. Maggi et al. (2013) also
reported a 52% reduction of N. ceranae spores per bee following
application of the bacteria L. Johnsonii metabolites in caged
bees. Finally, Corby-Harris et al. (2016) documented a significant
reduction of Nosema spores following the administration of the
endogenous strain P. apium. However, two key parameters from
these previous studies are different from those of the present
work, and could explain, at least partly, contrasted results in
terms of spore reduction. First, relatively low titers (ranging
from 1.103 to 1.104 spores per microliter of sugar syrup) of
N. ceranae spores were administrated to caged honey bees to
induce nosemosis (Maggi et al., 2013; Baffoni et al., 2016; Corby-
Harris et al., 2016). Here, administrated N. ceranae spore titer
was 100 to 1,000 times higher (1.106 spores per microliter of
sugar syrup). Second, probiotic titers administrated in the present
study were 100 to 1,000 times lower to previous studies (Baffoni
et al., 2016; Corby-Harris et al., 2016). Interestingly, Corby-
Harris et al. (2016) administrated a closely related strain of the
endogenous symbiont P. apium at 2.106 CFU per mL, which
is two thousand times higher than what was administrated in
the present work. Despite of this, N. ceranae titers remained
high enough, that the statistically significant reduction of spores
recorded in those previous studies was not biologically relevant
(Alberoni et al., 2016) to clearly reflect an antagonistic effect
on nosemosis, as reduction of spore load did not exceeded
40%, when compared to infected control group. Indeed, workers
from infected colonies exhibited mean nosema counts ranging
from 0.04 to 1.87.106 spores per bee (Traver and Fell, 2011).
In the caged bee trial of Corby-Harris et al. (2016) however,
the probiotic fed group housed a mean of 951.106 spores
per bee. Also, no survival improvement was recorded in all
experimental groups (Corby-Harris et al., 2016). This is not
surprising when considering our results as significant differences
in survival were observed after 14 days, whereas the duration
of the challenge with Nosema spores in Corby-Harris et al.
(2016) was 10 days. A peak of bee mortality at day 14 post
infection was previously observed (Dussaubat et al., 2012)
thus corroborating our results regarding N. ceranae infection
dynamics.
More importantly, the probiotic feed additive administration
protocol used by Corby-Harris et al. (2016) was quite different
from the present study. Corby-Harris et al. (2016) administrated
P. apium probiotic strain (2.106 CFUs) during 7 weeks into
the pollen patty on colony overwintering, and thus, prior to
the cage bee trial. In our experiment, probiotics strains (1.103
CFUs per mL) were administrated via sugar syrup during the
cage trial. Then, in the caged bee trial, young honeybees had
ad libitum access to unsterilized pollen patty. Such protocol
could have further improved overall survival, by providing bees
with both proteins and other bacterial strains. Furthermore,
Corby-Harris et al. (2016) used young spring bees from the
overwintering hives for their cages experience, whereas we used
winter bees. Taken together, the higher load of Nosema spores
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combined with lower concentration of probiotic candidates
and the lack of protein supply in the present work, likely
explain the absence of spore load decrease. However, all the
four probiotic candidates significantly improved bee survival
by 20–40%. Although it is yet not possible to state whether
probiotic effects could directly or indirectly interfere with
Nosema functional activity, it is reasonable to hypothesize
that probiotic effect allows honey bee to better tolerate high
loads of Nosema spores. Functional interaction of N. ceranae
with honey bee was essentially investigated by focusing on
enzyme regulation involved in detoxification process, immune
response, and the metabolism activity. At the gene-expression
level, honey bee midgut responded to N. ceranae infection
by increasing oxidative stress pathway with the concurrent
synthesis of antioxidant, defense, and protective molecules
(Dussaubat et al., 2012; Di Pasquale et al., 2013). At the
proteomic level, differential abundance of proteins associated
to metabolism, response to oxidative stress, and apoptosis
were measured between sensitive and resistant honey bees
(Kurze et al., 2016). Other studies focused on other genetic
mechanisms such as microRNA, which were suspected to
regulate host honey bee metabolism related genes in response to
N. ceranae infection (Huang et al., 2015, 2016). Overall, honey
bee health is a complex system resulting from a combination
of functional interacting networks between the bee host, the
symbiotic gut microorganisms (Anderson et al., 2011) and the
pathogens (Schwarz et al., 2015). To this respect, symbiotic
gut microorganisms play a central role in modulating energy
reserves and immune system development, which are key
actors for host defenses against parasites (Habtewold et al.,
2017; Knutie et al., 2017). Immune resistance mechanisms
can either prevent parasites and pathogens from invading
or eliminate them after invasion. Contrastingly to resistance
mechanisms, immune tolerance mechanisms primarily involve
both a lowered responsiveness to a given immune stimulus,
and the initiation of tissue repair processes to protect the host
from damage caused by the pathogen (Habtewold et al., 2017).
Honey bee tolerance regarding high N. ceranae spores was
documented in Huang et al. (2012), where a lower mortality
rates were correlated to an up-regulated immune response
in tolerant honey bee colonies day 6 post infection, when
compared to control groups. Therefore, a balance between
immune resistance and tolerancemechanisms ensures protection
from parasites and/or pathogens and, at the same time,
limits the tissue inflammation that may arise as a result of
excessive immune effector production. As it is now suspected
that host microbiota is fully involved in both resistance and
tolerance mechanisms (Vitetta et al., 2016), it is worth reviewing
known prophylactic and curative effects of both commercial
probiotic strains tested in the present study. Commercial
strains are administrated to a wide panel of host organisms
as food additives to increase zootechnical performances by
improving both metabolism and immune response (Denev
et al., 2013; Schoster et al., 2013; Hou et al., 2015). To this
respect, Bactocell R© (P. acidilactici) was demonstrated to exert
a protective action by stimulating the intestinal mucosal cells
activity inducing a positive response of the immune system of
the tilapia (Oreochromis niloticus; Standen et al., 2013). Overall,
administration of lactic acid bacteria (LAB) acts as an inhibitor
of bacterial infection propagation by activating the host immune
system (Servin, 2004). Interestingly, it was observed in mammals
that administration of LAB has the potential to alter gutmicrobial
diversity, affect intestinal barrier function, and modulate innate
immune response (e.g., via NF-κB pathway regulation) by
increasing mucosal barrier function, thus leading to a decrease
in translocation of bacteria and a subsequent decrease in the
ability of pathogenic bacteria to attach to the gut mucosa
(Reiff and Kelly, 2010). As insects and mammals share the
same NF-κBmediated induction of innate immunity (Hoffmann
et al., 1999), one of the putative mechanism underlying survival
improvement would be that Bactocell R© (P. acidilactici) may exert
an effect on the honey bee immune system itself rather than
directly interfere with Nosema activity. Then, other mechanism
favoring honey bee survival may be involved. Lactic Acid
bacteria (LAB) produce active antimicrobial molecules such as
bacteriocins, antibiotics, hydrogen peroxide, to name a few.
Those excreted molecules can control growth and/or survival of
surrounding microorganisms, including viruses, bacteria, yeast,
fungi, and protozoan parasites (Cleusix et al., 2007). Also, by
lowering the local intestinal pH with lactic acid, LAB are able
to inhibit growth of acid-sensitive organisms (Wohlgemuth
et al., 2010). Saccharomyces cerevisiae boulardii strains, to which
belong Levucell SB R©, are nonpathogenic yeast which have
proven experimental effectiveness in preventing and curating
diseases with a predominant inflammatory component, thus
indicating this probiotic might interfere with inflammatory
induced cellular signaling pathways (Palma et al., 2015).
Saccharomyces cerevisiae boulardii strains have a broad anti-
pathogenic action, due to its outer surface molecular profile,
which attaches to pathogenic bacteria such as Escherichia coli
and Salmonella. Furthermore, S. cerevisiae boulardii is able to
effectively compete with and displace parasitic yeast strains such
as Candida (Tomičić et al., 2016). S. cerevisiae boulardii also
produces anti-fungal substances such as capric, caprylic, and
caproic acids, which were proven to inhibit pathogenic yeast
growth in its close environment. Finally, S. cerevisiae boulardii
promotes the secretion of immune molecules (e.g., IgA), which
decrease the action of pro-inflammatory cytokines pathways
generated in response to pathogenic bacteria, toxins and antigens
(Qamar et al., 2001). Although little is known about the efficacy
of S. cerevisiae boulardii against protozoan parasites, three
studies documented a significant effect of this probiotic against
amoebiasis (Dinleyici et al., 2009), giardiasis (Besirbellioglu
et al., 2006), and infection with Blastocystis hominis (Dinleyici
et al., 2011). Finally, Lee et al. (2007) documented the
combination of P. acidilactici and S. cerevisiae boulardii on
coccidiose. However, the molecular mechanism remains to be
characterized.
Overall, experimental studies on both bacterial and yeast
probiotic action against parasites involving the secretion of an
active principle that can inhibit parasite development was only
documented for Cryptosporidium, Giardia, and Eimeria, even
though the molecular nature of the active component is still to
identify (Travers et al., 2011).
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CONCLUSION
This study confirms the potential of endogenous strains isolated
from the honey bee as efficient probiotic candidates to improve
honeybee survival. Then, we can conclude that the mortality
of honey bees was not directly related to N. ceranae spore
loads. Furthermore, as the experiment duration was longer
enough to cover up to two parasite life cycles (6 days), it
strongly suggests that all of the four probiotic strains did not
exert direct antagonism effect on the parasite development.
Our results, combined with the previous documented probiotic
effects of strains related to our four candidates, suggest that
mechanism of action is more related to tolerance, rather
than resistance against the parasite, potentially by improving
the immune system and tissue repair processes to protect
the host from damage caused by the parasite. Also, our
results, combined with the other experimental infection trials
with N. ceranae suggest that both Nosema inoculated titers
and probiotic strains concentrations have to be taken into
account to properly interpret results, as different mechanisms
of tolerance or resistance are potentially involved. Finally,
these encouraging preliminary results for the four probiotic
candidates were obtained in vivo with minimal nutritional
inputs (e.g., no proteins); therefore in situ validation is
necessary to fully assess the potential of these probiotic
candidates as sustainable preventive and curative tools against
nosemosis.
Extended studies are definitely needed to understand the
mechanisms underlying the functional interaction between the
honey bee, its microbiota, the probiotic strain and the parasite.
The metatranscriptomic approach, which consists in our case to
measure the gene expression level of all organisms inhabiting
the honey bee gut microbiome, including host epithelial cells, is
straightforward to better understand the molecular mechanisms
underlying the improvement of honey bee survival.
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